Bioequivalence Study of Idalopirdine Tablets 60 mg
NCT02371707
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Idalopirdine 60 mg formulation A (test)
DRUG:
Idalopirdine 60 mg formulation B (reference)
Sponsor
H. Lundbeck A/S